US2007148261A1PendingUtilityA1
Cancer treatment method
Est. expiryJan 16, 2021(expired)· nominal 20-yr term from priority
H10P 14/6922A61K 31/555A61P 43/00A61K 31/4196A61K 45/06A61K 31/475C23C 16/401A61K 31/519A61K 31/517A61P 35/00A61K 31/337
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
A method of treating cancer is described including administration of a 4-quinazolineamine and at least one other anti-neoplastic agent as well as a pharmaceutical combination including the 4-quinazolineamines.
Claims
exact text as granted — not AI-modified1 . A method of treating head and neck cancer in a mammal, comprising administering to said mammal a therapeutically effective amount of:
(a) a compound of formula II: or a salts, solvate or physiologically functional derivative thereof; and (b) at least one platinum coordination complex.
2 . A method of treating head and neck cancer in a mammal, comprising administering to said mammal a therapeutically effective amount of:
(a) a compound of formula II, or salt thereof; and (b) at least one platinum coordination complex.
3 . The method of claim 1 , wherein said at least one platinum coordination complex is selected from the group consisting of cisplatin and carboplatin.
4 . The method of claim 3 , wherein said at least one platinum coordination complex is cisplatin.
5 . The method of claim 3 , wherein said at least one platinum coordination complex is carboplatin.
6 . The method of claim 2 , wherein said at least one platinum coordination complex is selected from the group consisting of cisplatin and carboplatin.
7 . The method of claim 6 , wherein said at least one platinum coordination complex is cisplatin.
8 . The method of claim 6 , wherein said at least one platinum coordination complex is carboplatin.Cited by (0)
No later patents cite this yet.
References (0)
No backward citations on record.